IAQ relationship to human health
EDIAQI Wiki / Health impacts and toxicology / IAQ relationship to human health
Primary Burden: 2 million DALYs lost annually in the EU
Major Endpoints: Asthma, COPD, cardiovascular illness, lung cancer
Vulnerable Groups: Children, pregnant women, elderly, chronically ill
Key Mechanisms: Oxidative stress, systemic inflammation, genotoxicity
Explore further
What is IAQ?
Air Pollutants
Pollution Sources
Economics of IAQ
Jump to: Introduction • Five Pillars • Pathways • Vulnerable Groups • Clinical Endpoints • Emerging Contaminants • Action Framework
Introduction
Clean air is an essential prerequisite for human health, yet the air within homes, educational institutions, commercial offices, and healthcare premises contains a diverse mixture of airborne contaminants.[5] Modern Europeans spend roughly 90% of their daily time indoors, with approximately 70% of that time spent in residential settings.[4][6] Consequently, the indoor environment serves as the predominant driver of lifetime environmental pollutant inhalation.[7]
Globally, household air pollution causes substantial disease burden and premature mortality, falling heavily on children and women.[8] Across the European Union, ambient and indoor air pollution represents a major environmental health risk, contributing to hundreds of thousands of premature deaths annually.[2][9] Poor indoor air quality alone accounts for an estimated 2 million lost healthy life years (Disability-Adjusted Life Years, DALYs) every year in the EU.[1][2] Impaired indoor air quality extends far beyond temporary sensory stuffiness: it directly drives and accelerates chronic respiratory illness, cardiovascular disorders, metabolic syndrome, and malignancies.[10][11][4]
The Five Pillars of Indoor Air Quality
This page forms the fourth foundational pillar of the introductory IAQ knowledge framework:
Current page
Biological Mechanisms and Exposure Pathways
The physiological impact of indoor air pollution depends upon exposure duration, atmospheric concentration, and the physical state of the contaminant:[12]
- Acute Exposure Pathways: Immediate physical reactions occur when chemical vapors, acidic gases, or fine particles contact sensory nerve endings located in mucosal tissues of the eyes, nasal passages, and upper tracheobronchial tract.[12] Manifestations include lacrimation, rhinorrhea, nasal congestion, throat irritation, cephalalgia, and transient dizziness. In individuals with bronchial hyperreactivity, acute exposure triggers immediate reflex bronchoconstriction and asthmatic episodes.[5][4]
- Chronic Exposure Pathways: Persistent inhalation of fine particles (PM2.5), combustion products, and semi-volatile chemical species induces chronic cellular oxidative stress and sustained pulmonary tissue inflammation.[13] Systemic translocation of fine fractions promotes vascular endothelial dysfunction, genomic DNA damage, accelerated atherogenesis, and elevated lifetime cancer risk.[14][15]
Differential Susceptibility and Vulnerable Groups
Airborne pollutants do not affect all building occupants equally. Susceptibility is governed by physiological maturation, baseline health status, and domestic socio-environmental factors:[12][4]
Children
Children represent a uniquely sensitive sub-population due to distinct anatomical, physiological, and behavioral parameters:[16][17]
- Elevated Minute Ventilation: Relative to total body mass, children exhibit elevated respiratory rates, inhaling a substantially higher volume of air and associated air pollutants per kilogram compared to adults.[17][16]
- Developing Organ Systems: Pulmonary tissue, bronchial architecture, immune surveillance, and metabolic detoxification systems are undergoing maturation, making biological tissues susceptible to structural remodeling.[16]
- Microenvironmental Exposure: Infants and young children spend substantial periods playing close to floor surfaces, directly interacting with resuspendable dust, settled particulate matter, and semi-volatile organic compounds.[15]
- Observed Dose-Response Associations: Epidemiological and cohort investigations demonstrate consistent dose-response patterns. Increases of 10 µg/m³ in coarse particulate fractions (PM2.5-10) are associated with elevated days of coughing and wheezing, while fine particulate matter (PM2.5) increases correlate with higher rescue medication reliance in asthmatic children.[4][18]
Maternal and Prenatal Health
Maternal exposure to combustion by-products, fine particulate matter, and solvent chemicals during pregnancy is clinically correlated with impaired fetal growth patterns.[19][8] Inhaled fine particles that translocate into maternal circulation induce systemic inflammatory cascades, which have been linked in epidemiological cohorts to lower infant birth weights, intrauterine growth restriction, and altered neonatal immune profiles.[19][4]
Older Adults
Biological aging is accompanied by progressive declines in respiratory clearance kinetics, including decreased mucociliary escalator function and altered immune resilience.[12] Chronic inhalation of particulate matter and chemical oxidants accelerates arterial stiffening, worsens chronic obstructive pulmonary disease, and is associated with accelerated cognitive impairment.[20][2]
Individuals with Pre-Existing Conditions
Individuals diagnosed with bronchial asthma, chronic bronchitis, COPD, or cardiovascular diseases possess reduced physiological reserve.[7] Low-level indoor concentrations of nitrogen dioxide (NO2) from domestic gas appliances or volatile chemicals like formaldehyde induce marked airway hyperresponsiveness and epithelial remodeling.[5][21] In patients with ischemic heart disease, particulate inhalation elevates inflammatory biomarkers, promoting atherosclerotic plaque instability.[22][23]
Socio-Environmental Vulnerability
Socioeconomic factors strongly correlate with indoor environmental exposures across Europe.[24][25] Lower-income households frequently occupy older building stock characterized by poor thermal insulation, insufficient mechanical ventilation, structural dampness, and visible mould colonization.[2] Reliance on unvented domestic heating appliances coupled with close proximity to high-density traffic corridors creates pronounced health disparities.[2][15]
Clinical Endpoints and Health Effects
Indoor contaminants affect multiple biological systems through distinct pathophysiological mechanisms:
Sensory Irritation and Sick Building Syndrome (SBS)
Airborne chemical irritants directly stimulate sensory nerve fibers in mucous membranes, causing ocular burning, nasal congestion, and pharyngeal irritation.[26][12] These non-specific clinical symptoms are hallmarks of Sick Building Syndrome (SBS), frequently driven by inadequate fresh air exchange, elevated total volatile organic compounds (TVOCs) from cleaning agents, and persistent formaldehyde off-gassing from engineered wood furnishings.[27][6]
Cognitive Function and Central Nervous System Effects
Airborne contaminants in enclosed classrooms and offices impair neurological focus, executive decision-making, and academic performance:[28]
- Carbon Dioxide (CO2): Elevated indoor carbon dioxide levels exceeding 1000 to 1200 ppm indicate insufficient air exchange, correlating with drowsiness, diminished concentration, and slower decision-making speed.[28][29]
- Combustion Gases and Particulates: Exposure to indoor nitrogen dioxide, nitric oxide, and fine particles is linked to reduced attention capacity.[12][28]
- Long-Term Neurological Risks: Chronic exposure to combustion-derived particles infiltrating from urban traffic corridors is associated with accelerated cognitive decline in elderly populations.[20][2]
Respiratory and Allergic Manifestations
- Asthma Exacerbation: Fine particulate matter (PM2.5), combustion emissions from unvented gas cookers, and environmental tobacco smoke drive bronchial inflammation and emergency healthcare utilization.[21][30] Second-hand smoke exposure disrupts immunoregulatory balances, exacerbating severe asthma phenotypes.[4]
- Dampness and Microbial Bioaerosols: Persistent structural dampness and fungal proliferation increase the risk of respiratory infections, allergic rhinitis, and asthma development by 30% to 50%.[3] Dust mite allergens concentrated in carpets and upholstered furniture trigger persistent allergic inflammation.[4][31]
- Acute Carbon Monoxide (CO) Toxicity: Incomplete combustion in malfunctioning domestic heating appliances generates odorless CO gas, which competitively binds with hemoglobin to form carboxyhemoglobin, impairing cellular oxygen delivery and causing tissue hypoxia.[5]
The Indoor Microbiome and Immune Modulation
Humans co-exist with complex microbial communities present within domestic dust reservoirs.[32] Epidemiological cohort evaluations demonstrate that early-life microbial exposure patterns influence immunological maturation:
- Exposure to diverse environmental microbiomes during infancy provides protective immune conditioning against asthma and allergic sensitization.[4][32]
- Fungal and bacterial richness in infant bedding dust is associated with modulated risks of childhood asthma development.[33][4]
- Dust samples exhibiting rural-type bacterial diversity offer distinct immune-regulatory benefits compared to sterile, urbanized dust matrices.[33]
Cardiovascular and Systemic Morbidity
Inhaled fine and ultrafine particles penetrate pulmonary alveolar walls to access systemic blood circulation:[8]
- Vascular Inflammation: Particulate exposure stimulates systemic oxidative stress, endothelial damage, and prothrombotic platelet activation, contributing to ischemic heart disease and cerebrovascular stroke.[8][4]
- Ozone Reactivity: Infiltrating ambient ozone and secondary indoor oxidants can elevate arterial blood pressure and cardiovascular stress markers even at moderate indoor concentrations.[11][34]
- Metabolic Disruption: Long-term exposure to combustion particulates and nitrogen oxides is epidemiologically linked to biomarker alterations associated with metabolic syndrome and diabetes mellitus.[35][2]
Carcinogenic Chemical and Radiological Risks
Several common indoor air pollutants are classified as Group 1 known human carcinogens by the International Agency for Research on Cancer (IARC):[36]
- Radon (²²²Rn): A naturally occurring radioactive noble gas seeping from soil and rock into basements and ground floors. Inhaled alpha-emitting decay progeny deposit in bronchial epithelium, causing direct double-strand DNA breaks. Radon represents the leading cause of lung cancer in non-smokers, prompting European Council Directive 2013/59/EURATOM to establish national reference levels.[37][38]
- Polycyclic Aromatic Hydrocarbons (PAHs): Emitted during domestic solid fuel combustion, cooking, and smoking. High molecular weight species such as benzo[a]pyrene (BaP) adsorb onto fine inhalable particles, elevating lifetime cancer risk in poorly ventilated residential settings.[39][15]
- Volatile Organics (Formaldehyde and Benzene): Formaldehyde off-gases continuously from composite wood resins and adhesives, while benzene originates from tobacco smoke, attached garages, and stored solvents. Chronic inhalation is linked to nasopharyngeal carcinoma and myeloid leukemia.[5][15]
Emerging Contaminants of Concern
Scientific research within the EDIAQI framework focuses on under-regulated airborne contaminants that pose potential health hazards:
- Ultrafine Particles (UFPs, < 100 nm): Generated indoors during high-temperature frying, baking, candle combustion, and biomass heating.[40][39] Possessing negligible mass but elevated particle number concentrations and high surface-area-to-mass ratios, UFPs evade upper respiratory filtration and translocate across the alveolar-capillary barrier into the systemic circulation.[40][4]
- Black Carbon (BC): A carbonaceous fraction of fine particulate matter produced by incomplete fuel combustion. Black carbon acts as a carrier substrate for toxic metals and adsorbed organic compounds, depositing deep in pulmonary alveoli.[4]
- Indoor Airborne Microplastics: Mechanical abrasion of synthetic clothing, polyester curtains, polyurethane foam, and polymer flooring releases synthetic fibrous debris into indoor air.[41] Inhaled microplastic fibers can lodge in alveolar tissue, releasing bound plasticizers and chemical additives.[41][4]
[+] Click here to view technical details on cellular toxicology and experimental assays
Investigation of the biological mechanisms of action (MoA) connecting indoor exposures to clinical endpoints utilizes human biomonitoring, in vitro (2D and 3D cell models), and in vivo models in accordance with the 3R principles (Replace, Reduce, Refine):[4]
- Primary DNA Damage: Evaluated using the alkaline comet assay to quantify single- and double-strand DNA breaks in human alveolar epithelial cells (A549), hepatic spheroids (HepG2), and peripheral blood lymphocytes (PBLs).[4]
- Genomic Instability: Measured via the cytokinesis-block micronucleus (CBMN) assay in peripheral lymphocytes and non-invasive exfoliated buccal cells of children, detecting chromosomal breakage, whole chromosome loss, nucleoplasmic bridges, and nuclear buds.[42][4]
- Histone Phosphorylation (γ-H2AX): Automated fluorescence microscopy tracks double-strand break response markers in cellular models exposed to indoor particulate and chemical extracts.[43][4]
- Epigenetic Alterations: Examination of genome-wide DNA methylation signatures that modulate immune regulatory pathways and allergic susceptibility in pediatric cohorts.[4]
Action Framework: Mitigating Health Risks
Protecting occupants from indoor environmental health risks follows the practical stages of the EDIAQI Decision Tree:
| Decision Stage | Key Indicators and Observations | Practical Remediation Measures |
|---|---|---|
| Why Measure? | Recurrent headaches, lethargy, ocular or upper airway dryness, morning congestion, worsening asthma symptoms, or perceptible musty odors. | Establish baseline environmental metrics; verify whether carbon dioxide exceeds 1000 ppm or if PM2.5 concentrations exceed health guidelines. |
| How to Measure? | Deploy calibrated continuous multi-sensor monitors or accredited reference instruments. | Mount sensors at breathing height (1.0 to 1.5 m from the floor; ~1.0 m in classrooms); maintain at least 1.0 m clearance from doors, windows, and heat radiators. |
| What is the Issue? |
|
Compare indoor concentration trends against outdoor reference levels to identify whether contaminants originate within the premises or infiltrate from outdoors. |
| What Now? | Structured remediation plan for residents, school administrators, and property managers. |
|
Target Audience Practical Application Matrix
| Target Audience | Practical Value and Action |
|---|---|
| Residents and Families | Ensure regular cross-ventilation, operate cooker hoods while preparing food, avoid burning incense and candles in unventilated rooms, and clean settled dust with damp methods or HEPA-filtered vacuum cleaners. |
| Schools and Kindergartens | Track classroom CO2 levels to maintain levels below 1000 ppm, schedule intensive window airing during breaks, use solvent-free art materials, and keep relative humidity below 60% to suppress biological allergens. |
| Facility and Building Managers | Maintain ventilation systems according to EN 16798 standards, replace air filters regularly, remediate water leaks within 24 to 48 hours to prevent fungal growth, and test ground-contact buildings for radon ingress. |
| Municipalities and Public Health Bodies | Incorporate indoor air quality benchmarks into municipal building renovation tenders, promote targeted public awareness campaigns on domestic combustion risks, and focus interventions on vulnerable communities. |
Related Wiki Pages
References
- ↑ 1.0 1.1 Asikainen, A., Carrer, P., Kephalopoulos, S., de Oliveira Fernandes, E., Wargocki, P., & Hänninen, O. (2016). Reducing burden of disease from residential indoor air exposures in Europe (HEALTHVENT project). Environmental Health, 15(Suppl 1), S35.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 European Environment Agency. (2020). Healthy environment, healthy lives: how the environment influences health and well-being in Europe. EEA Report No 21/2019; published September 8, 2020.
- ↑ 3.0 3.1 World Health Organization. (2009). WHO guidelines for indoor air quality: dampness and mould.
- ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 4.16 4.17 4.18 4.19 Lovrić, M., et al. (2025). Evidence driven indoor air quality improvement: An innovative and interdisciplinary approach to improving indoor air quality. BioFactors, 51(1), e2126.
- ↑ 5.0 5.1 5.2 5.3 5.4 World Health Organization. (2010). WHO guidelines for indoor air quality: selected pollutants.
- ↑ 6.0 6.1 Halios, C. H., Landeg-Cox, C., Lowther, S. D., Middleton, A., Marczylo, T., & Dimitroulopoulou, S. (2022). Chemicals in European residences: Part I: A review of emissions, concentrations and health effects of volatile organic compounds (VOCs). Science of the Total Environment, 839, 156201.
- ↑ 7.0 7.1 Cincinelli, A., & Martellini, T. (2017). Indoor air quality and health. International Journal of Environmental Research and Public Health, 14(11), 1286.
- ↑ 8.0 8.1 8.2 8.3 World Health Organization. (2025, December 16). Household air pollution. Fact sheet; current version of the webpage originally registered under the legacy ID WHO_2023. Accessed October 10, 2026.
- ↑
- ↑ European Commission. EU clean air policy.
- ↑ 11.0 11.1 World Health Organization. (2021). WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide.
- ↑ 12.0 12.1 12.2 12.3 12.4 12.5 Scientific Committee on Health and Environmental Risks (SCHER). (2008). Opinion on risk assessment on indoor air quality. European Commission, Directorate-General for Health and Consumer Protection, Brussels.
- ↑ González-Caballero, M. del C., de Alba-Gonzalez, M., & Tarazona, J. V. (2024). Pollution, indoor air. In Encyclopedia of Toxicology (4th ed., Vol. 7, pp. 787-799). Elsevier.
- ↑ Stading, R., et al. (2021). Molecular mechanisms of pulmonary carcinogenesis by polycyclic aromatic hydrocarbons (PAHs): Implications for human lung cancer. Seminars in Cancer Biology, 76, 3-16.
- ↑ 15.0 15.1 15.2 15.3 15.4 Račić, N., et al. (2025). Volatile Organic Compounds (VOCs) and Polycyclic Aromatic Hydrocarbons (PAHs) in Indoor Environments: A Review and Analysis of Measured Concentrations in Europe. Indoor Air, 2025(1), 5945455.
- ↑ 16.0 16.1 16.2 European Environment Agency. (2023). Air pollution and children's health. (Briefing no. 07/2023)
- ↑ 17.0 17.1 Bennett, W. D., & Zeman, K. L. (1998). Deposition of fine particles in children spontaneously breathing at rest. Inhalation Toxicology, 10(9), 831-842.
- ↑ Janssen, N. A. H., et al. (2003). The relationship between air pollution from heavy traffic and allergic sensitization, bronchial hyperresponsiveness, and respiratory symptoms in Dutch schoolchildren. Environmental Health Perspectives, 111(12), 1512–1518.
- ↑ 19.0 19.1 Šrám, R. J., et al. (2005). Ambient air pollution and pregnancy outcomes: a review of the literature. Environmental Health Perspectives, 113(4), 375-382.
- ↑ 20.0 20.1 Ranft, U., et al. (2009). Long-term exposure to traffic-related particulate matter impairs cognitive function in the elderly. Environmental Research, 109(8), 1004-1011.
- ↑ 21.0 21.1 Tiotiu, A. I., et al. (2020). Impact of air pollution on asthma outcomes. International Journal of Environmental Research and Public Health, 17(17), 6212.
- ↑ Lelieveld, J., et al. (2019). Cardiovascular disease burden from ambient air pollution in Europe reassessed using novel hazard ratio functions. European Heart Journal, 40(20), 1590-1596.
- ↑ Mustafić, H., et al. (2012). Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA, 307(7), 713-721.
- ↑ Laurent, É. (2022). Air (ine)quality in the European Union. Current Environmental Health Reports, 9(2), 123-129.
- ↑ WHO Regional Office for Europe. (2019). Environmental health inequalities in Europe: Second assessment report. Copenhagen: WHO Regional Office for Europe.
- ↑ Wolkoff, P. (2008). "Healthy" eye in office-like environments. Environment International, 34(8), 1204-1214.
- ↑ Jafari, M. J., et al. (2015). Association of sick building syndrome with indoor air parameters. Tanaffos, 14(1), 55-62.
- ↑ 28.0 28.1 28.2 Sadrizadeh, S., et al. (2022). Indoor air quality and health in schools: A critical review for developing the roadmap for the future school environment. Journal of Building Engineering, 57, 104908.
- ↑ Mendell, M. J., & Heath, G. A. (2005). Do indoor pollutants and thermal conditions in schools influence student performance? A critical review of the literature. Indoor Air, 15(1), 27-52.
- ↑ Wang, Z., et al. (2015). Effects of secondhand smoke exposure on asthma morbidity and health care utilization in children: A systematic review and meta-analysis. Annals of Allergy, Asthma & Immunology, 115(5), 396-401.e2.
- ↑ Gaffin, J. M., & Phipatanakul, W. (2009). The role of indoor allergens in the development of asthma. Current Opinion in Allergy and Clinical Immunology, 9(2), 128-135.
- ↑ 32.0 32.1 Gupta, S., et al. (2020). Environmental shaping of the bacterial and fungal community in infant bed dust and correlations with the airway microbiota. Microbiome, 8, 115.
- ↑ 33.0 33.1 Lehtimäki, J., et al. (2021). Urbanized microbiota in infants, immune constitution, and later risk of atopic diseases. Journal of Allergy and Clinical Immunology, 148(1), 234-243.
- ↑ Day, D. B., et al. (2017). Association of ozone exposure with cardiorespiratory pathophysiologic mechanisms in healthy adults. JAMA Internal Medicine, 177(9), 1344-1353.
- ↑ Nassan, F. L., et al. (2021). Ambient PM2.5 species and ultrafine particle exposure and their differential metabolomic signatures. Environment International, 151, 106447.
- ↑ International Agency for Research on Cancer (IARC). (2016). Outdoor air pollution. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 109. Lyon, France: IARC. Copyright year 2016; online publication December 17, 2015. The Working Group met in October 2013.
- ↑ Darby, S., et al. (2005). Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ, 330, 223.
- ↑ Council of the European Union. (2013, December 5). Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation. Official Journal of the European Union, L 13, 1-73.
- ↑ 39.0 39.1 Lovrić, M., Račić, N., Pehnec, G., Horvat, T., Lovrić Štefiček, M. J., & Jakovljević, I. (2024). Indoor Polycyclic Aromatic Hydrocarbons: Relationship to Ambient Air, Risk Estimation, and Source Apportionment Based on Household Measurements. Atmosphere, 15(12), 1525.
- ↑ 40.0 40.1 Manigrasso, M., Vitali, M., Protano, C., & Avino, P. (2018). Ultrafine particles in domestic environments: Regional doses deposited in the human respiratory system. Environment International, 118, 134-145.
- ↑ 41.0 41.1
- ↑ Bonassi, S., et al. (2021). DNA damage in circulating leukocytes measured with the comet assay may predict the risk of death. Scientific Reports, 11, 16793.
- ↑ Štampar, M., Tomc, J., Filipič, M., & Žegura, B. (2019). Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing. Archives of Toxicology, 93(11), 3321-3333.